Impact of postnatal steroids on peripheral avascular retina and severity of retinopathy of prematurity
Open Access
- 8 June 2023
- journal article
- research article
- Published by Springer Nature in Pediatric Research
- Vol. 94 (6) , 1966-1972
Abstract
Background We investigated the role of postnatal steroids on the severity of retinopathy of prematurity (ROP) and its impact on peripheral avascular retina (PAR). Methods A retrospective cohort study of infants born at ≤32 weeks gestation and/or birth weight ≤1500 g. Demographics, the dose and duration of steroid treatment, and age when full retinal vascularization occurred were collected. The primary outcomes were the severity of ROP and time to full vascularization of the retina. Results A total of 1695 patients were enrolled, 67% of whom received steroid therapy. Their birth weight was 1142 ± 396 g and gestational age was 28.6 ± 2.7 weeks. The total hydrocortisone-equivalent dose prescribed was 28.5 ± 74.3 mg/kg. The total days of steroid treatment were 8.9 ± 35.1 days. After correction for major demographic differences, infants who received a higher cumulative dose of steroids for a longer duration had a significantly increased incidence of severe ROP and PAR (P < 0.001). For each day of steroid treatment, there was a 3.2% increase in the hazard of the severe form of ROP (95% CI: 1.022–1.043) along with 5.7% delay in achieving full retinal vascularization (95% CI: 1.04–1.08) (P < 0.001). Conclusion Cumulative dose and duration of postnatal steroid use were independently associated with the severity of ROP and PAR. Thus, postnatal steroids should be used very prudently. Impact We report ROP outcomes in a large cohort of infants from two major healthcare systems where we have studied the impact of postnatal steroids on the severity of ROP, growth, and development of retinal vessels. After correcting our data for three major outcome measures, we show that high-dose postnatal steroids used for a prolonged duration of time are independently associated with severe ROP and delay in retinal vascularization. Postnatal steroids impact the visual outcomes of VLBW infants significantly, so their clinical use needs to be moderated.Keywords
This publication has 53 references indexed in Scilit:
- Postnatal Corticosteroids to Prevent or Treat Bronchopulmonary DysplasiaPediatrics, 2010
- Protective effects of triamcinolone acetonide upon the upregulation and phosphorylation of GAP 43 in an animal model of retinopathy of prematurityActa Ophthalmologica, 2010
- Late postnatal systemic steroids predispose to retinopathy of prematurity in very‐low‐birth‐weight infants: a comparative studyActa Paediatrica, 2008
- Antenatal Dexamethasone Treatment Leads to Changes in Gene Expression in a Murine Late PlacentaPlacenta, 2007
- Triamcinolone Reduces Neovascularization, Capillary Density and IGF-1 Receptor Phosphorylation in a Model of Oxygen-Induced RetinopathyInvestigative Ophthalmology & Visual Science, 2006
- Triamcinolone Acetonide Destabilizes VEGF mRNA in Müller Cells under Continuous Cobalt StimulationInvestigative Ophthalmology & Visual Science, 2005
- Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivoBritish Journal of Ophthalmology, 2005
- Association of Postnatal Dexamethasone Use and Fungal Sepsis in the Development of Severe Retinopathy of Prematurity and Progression to Laser Therapy in Extremely Low-Birth-Weight InfantsJournal of Perinatology, 2001
- Refractory hypotension in preterm infants with adrenocortical insufficiencyArchives of Disease in Childhood - Fetal and Neonatal Edition, 2001
- Retinal maturation is delayed by repeated, but not single, maternal injections of betamethasone in sheepEye, 2000